News
We’re Hiring Community Behavioral Health Faculty Members!
January 5, 2022
The Department of Population Health Sciences at UT Health San Antonio — home to the Salud America! program in the Institute for Health Promotion Research — is seeking two applicants for open-rank faculty positions in community behavioral health and biostatistics. The two positions will also serve in the Population Science and Prevention research program at […]
Exploring the Burden of Stomach Cancer among Latinos
November 29, 2021
Stomach cancer, also called gastric cancer, disproportionately impacts Latinos. In fact, U.S. Latino men and women are twice as likely as their White peers to develop invasive gastric cancer, according to a 2021 report. But little is known about regional differences. That is why Dr. Dorothy Long Parma of UT Health San Antonio and her […]
Dr. Amelie Ramirez to Serve as Chair AACR’s Women in Cancer Research Council
November 10, 2021
Dr. Amelie G. Ramirez, director of the Institute for Health Promotion Research (IHPR) at UT Health San Antonio and a leading health disparities researcher, will serve as the 2021-2022 chair of the the Women in Cancer Research Council of the American Association for Cancer Research (AACR). The council organizes the activities of the members of […]
Latino Cancer Survivors, We Need You!
October 25, 2021
Are you a Latino cancer survivor? Volunteer for the Avanzando Caminos study at UT Health San Antonio! Avanzando Caminos aims to enroll 1,500 Latino cancer survivors in South Texas and 1,500 more in Miami to help unpack the social, cultural, behavioral, mental, biological, and medical influences on post-cancer life. The study is funded by the […]
Sobrevivientes de cáncer Latinos, ¡Los Necesitamos!
October 25, 2021
¿Es usted un sobreviviente de cáncer Latino? ¡Participe en el estudio Avanzando Caminos de UT Health San Antonio! Avanzando Caminos tiene como objetivo inscribir 1.500 sobrevivientes de cáncer Latinos en el Sur de Texas y 1.500 más en Miami para estudiar las influencias sociales, culturales, mentales, biológicas y médicas que afectan la vida después del […]
IHPR’s Dr. Patricia Chalela: Involving Technology into Latino Health Promotion Research
June 4, 2021
Patricia Chalela has always loved working in public health and being a valuable member of a team. Chalela is an associate professor at the Institute for Health Promotion Research (IHPR) at UT Health San Antonio. Here she is an integral part of a team that studies how texting helps people quit smoking, trains students in […]
IHPR’s Dr. Daniel Carlos Hughes: Studying Holistic Health, Cancer Prevention
April 15, 2021
Daniel Carlos Hughes thought he wanted to be a chemical engineer. He worked at Dow Chemical for 23 years, moving up to a middle management position. But then he had a midlife crisis. Now he works as a kinesiologist focuses on sport and exercise psychology. He researches holistic interventions for cancer prevention and with an […]
IHPR Launches Community Cancer Survey
January 5, 2021
The Institute for Health Promotion Research (IHPR) at UT Health San Antonio is launching a community-wide survey to examine how South Texans perceive cancer, their knowledge of cancer risk, and their behaviors around reducing risk. Survey results will provide important guidance for cancer care practices, services, and research provided by the Mays Cancer Center across […]
‘Next-Level’ Patient Navigation Improves Quality of Life for Latino Cancer Survivors
March 11, 2020
Latino cancer survivors who have a “next-level” patient navigator—one who regularly calls to offer support and culturally tailored materials—have better health-related quality of life than survivors with a more passive navigator, according to a new study by UT Health San Antonio, University of Miami, and Northwestern University. The study, published in the journal Cancer, provided […]
Amelie Ramirez Leads Push for Progress in Latino Cancer
March 5, 2020
We are in the “golden age” of cancer drug development with over 50 drugs approved for cancer treatment in the past three years. But things aren’t golden for everyone. In fact, of all the clinical trials for those 50 drug approvals, fewer than 10% of participants were Latino or other people of color. That is […]